Sana Biotechnology, Inc.
(NASDAQ : SANA)

( )
SANA After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
MRNAModerna, Inc. -0.08%132.190.0%$1591.35m
NVAXNovavax, Inc. 10.59%174.8492.9%$1076.02m
OCGNOcugen, Inc. -2.56%8.740.0%$968.48m
AMGNAmgen, Inc. 2.62%227.731.3%$602.23m
REGNRegeneron Pharmaceuticals, Inc. 2.71%461.572.7%$535.67m
VRTXVertex Pharmaceuticals, Inc. 2.02%211.981.9%$514.02m
GILDGilead Sciences, Inc. 2.20%64.621.0%$510.98m
ILMNIllumina, Inc. -0.19%398.853.5%$481.19m
BIIBBiogen, Inc. 2.71%270.711.7%$377.15m
ALXNAlexion Pharmaceuticals, Inc. 1.11%150.102.0%$364.81m
BNGOBioNano Genomics, Inc. 3.62%7.150.0%$275.11m
CRSPCRISPR Therapeutics AG -0.73%114.650.6%$266.37m
EXASEXACT Sciences Corp. 0.51%121.6418.4%$225.25m
SGENSeagen Inc. 2.68%149.355.8%$209.86m
VXRTVaxart, Inc. 1.69%6.020.0%$177.29m

Company Profile

Sana Biotechnology, Inc. engages in the research and development of engineered cells as medicine. It focuses in identifying and developing potential product candidates, executing preclinical studies, and acquiring technology. The company was founded by Steven D. Harr, Noubar B. Afeyan, Robert Taylor Nelsen, and Hans Edgar Bishop on July 13, 2018 and is headquartered in Seattle, WA.